228 related articles for article (PubMed ID: 8399986)
1. Relaxation of isolated coronary arteries by angiotensin-converting enzyme inhibitors: role of endothelium-derived kinins.
Hecker M; Bara AT; Busse R
J Vasc Res; 1993; 30(5):257-62. PubMed ID: 8399986
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin-converting enzyme inhibitors unmask endogenous kinin production by bovine coronary artery endothelium.
Hecker M; Bara AT; Busse R
Eur Heart J; 1993 Nov; 14 Suppl I():161-3. PubMed ID: 8293768
[TBL] [Abstract][Full Text] [Related]
3. Role of endothelium-derived bradykinin in the control of vascular tone.
Hecker M; Dambacher T; Busse R
J Cardiovasc Pharmacol; 1992; 20 Suppl 9():S55-61. PubMed ID: 1282631
[TBL] [Abstract][Full Text] [Related]
4. Endothelium-derived bradykinin: implications for angiotensin-converting enzyme-inhibitor therapy.
Busse R; Fleming I; Hecker M
J Cardiovasc Pharmacol; 1993; 22 Suppl 5():S31-6. PubMed ID: 7508049
[TBL] [Abstract][Full Text] [Related]
5. Potentiation by ACE inhibitors of the dilator response to bradykinin in the coronary microcirculation: interaction at the receptor level.
Hecker M; Pörsti I; Bara AT; Busse R
Br J Pharmacol; 1994 Jan; 111(1):238-44. PubMed ID: 8012702
[TBL] [Abstract][Full Text] [Related]
6. Local potentiation of bradykinin-induced vasodilation by converting-enzyme inhibition in isolated coronary arteries.
Auch-Schwelk W; Bossaller C; Claus M; Graf K; Gräfe M; Fleck E
J Cardiovasc Pharmacol; 1992; 20 Suppl 9():S62-7. PubMed ID: 1282632
[TBL] [Abstract][Full Text] [Related]
7. Stimulation of endothelial autacoid formation by inhibitors of angiotensin-converting enzyme.
Hecker M; Benzing T; Busse R
Agents Actions Suppl; 1992; 38 ( Pt 3)():163-70. PubMed ID: 1281378
[TBL] [Abstract][Full Text] [Related]
8. Femtomolar bradykinin-induced relaxation of isolated bovine coronary arteries, mediated by endothelium-derived nitric oxide.
Nakamura Y; Kawagoe K; Obi T; Miyamoto A; Ishiguro S; Nishio A
J Vet Pharmacol Ther; 1998 Aug; 21(4):304-8. PubMed ID: 9731953
[TBL] [Abstract][Full Text] [Related]
9. Potentiation of endothelium-dependent relaxations to bradykinin by angiotensin I converting enzyme inhibitors in canine coronary artery involves both endothelium-derived relaxing and hyperpolarizing factors.
Mombouli JV; Illiano S; Nagao T; Scott-Burden T; Vanhoutte PM
Circ Res; 1992 Jul; 71(1):137-44. PubMed ID: 1318793
[TBL] [Abstract][Full Text] [Related]
10. Release of nitric oxide by angiotensin-(1-7) from porcine coronary endothelium: implications for a novel angiotensin receptor.
Pörsti I; Bara AT; Busse R; Hecker M
Br J Pharmacol; 1994 Mar; 111(3):652-4. PubMed ID: 8019744
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of cytosolic calcium, prostacyclin and nitric oxide by bradykinin and the ACE inhibitor ramiprilat in porcine brain capillary endothelial cells.
Wiemer G; Popp R; Schölkens BA; Gögelein H
Brain Res; 1994 Feb; 638(1-2):261-6. PubMed ID: 7515323
[TBL] [Abstract][Full Text] [Related]
12. Local regulation of vascular tone by bradykinin and angiotensin converting enzyme inhibitors.
Auch-Schwelk W; Kuchenbuch C; Claus M; Walther B; Bossaller C; Friedel N; Graf K; Gräfe M; Fleck E
Eur Heart J; 1993 Nov; 14 Suppl I():154-60. PubMed ID: 8293767
[TBL] [Abstract][Full Text] [Related]
13. Ramiprilat enhances endothelial autacoid formation by inhibiting breakdown of endothelium-derived bradykinin.
Wiemer G; Schölkens BA; Becker RH; Busse R
Hypertension; 1991 Oct; 18(4):558-63. PubMed ID: 1655653
[TBL] [Abstract][Full Text] [Related]
14. Pharmacologic differentiation between endothelium-dependent relaxations sensitive and resistant to nitro-L-arginine in coronary arteries.
Holzmann S; Kukovetz WR; Windischhofer W; Paschke E; Graier WF
J Cardiovasc Pharmacol; 1994 May; 23(5):747-56. PubMed ID: 7521457
[TBL] [Abstract][Full Text] [Related]
15. Endothelium-dependent relaxation and hyperpolarization evoked by bradykinin in canine coronary arteries: enhancement by exercise-training.
Mombouli JV; Nakashima M; Hamra M; Vanhoutte PM
Br J Pharmacol; 1996 Feb; 117(3):413-418. PubMed ID: 8821528
[TBL] [Abstract][Full Text] [Related]
16. Converting-enzyme inhibitors potentiate bradykinin-induced relaxation in vitro.
Félétou M; Germain M; Teisseire B
Am J Physiol; 1992 Mar; 262(3 Pt 2):H839-45. PubMed ID: 1558194
[TBL] [Abstract][Full Text] [Related]
17. ACE inhibitors are endothelium dependent vasodilators of coronary arteries during submaximal stimulation with bradykinin.
Auch-Schwelk W; Bossaller C; Claus M; Graf K; Gräfe M; Fleck E
Cardiovasc Res; 1993 Feb; 27(2):312-7. PubMed ID: 8386065
[TBL] [Abstract][Full Text] [Related]
18. Converting enzyme inhibitor-stimulated formation of nitric oxide and prostacyclin in endothelial cells from bovine aorta is mediated by endothelium-derived bradykinin.
Wiemer G; Schölkens BA; Becker RH
Agents Actions Suppl; 1992; 38 ( Pt 3)():196-200. PubMed ID: 1334350
[TBL] [Abstract][Full Text] [Related]
19. ACE inhibition, endothelial function and coronary artery lesions. Role of kinins and nitric oxide.
Mombouli JV
Drugs; 1997; 54 Suppl 5():12-22. PubMed ID: 9429841
[TBL] [Abstract][Full Text] [Related]
20. Local production of kinins contributes to the endothelium dependent relaxations evoked by converting enzyme inhibitors in isolated arteries.
Mombouli JV; Illiano S; Vanhoutte PM
Agents Actions Suppl; 1992; 38 ( Pt 3)():186-95. PubMed ID: 1462858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
